Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 17, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012972.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
tyrosine aminotransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tyrosine aminotransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tyrosine aminotransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC326033 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
vacuolar protein sorting-associated protein 4A
syntrophin, beta 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
syntrophin, beta 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
syntrophin, beta 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
syntrophin, beta 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
syntrophin, beta 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
syntrophin, beta 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
syntrophin, beta 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
U3 small nucleolar RNA-associated protein 4 homolog
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
chromosome transmission fidelity protein 8 homolog
hyaluronan synthase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hyaluronan synthase 3, transcript variant X2
transport and golgi organization 6 homolog (Drosophila), transcript variant X2
transport and golgi organization 6 homolog (Drosophila), transcript variant X1
transport and Golgi organization protein 6 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cadherin 15, type 1, M-cadherin (myotubule), transcript variant X2
cadherin 15, type 1, M-cadherin (myotubule), transcript variant X1
sulfhydryl oxidase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sulfhydryl oxidase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
sulfhydryl oxidase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
acyl-CoA synthetase family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
malonate--CoA ligase ACSF3, mitochondrial isoform X1
acyl-CoA synthetase family member 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
malonate--CoA ligase ACSF3, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
trafficking protein particle complex subunit 2L
trafficking protein particle complex subunit 2-like protein
zinc finger CCCH domain-containing protein 18
KIAA0513 ortholog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
KIAA0513 ortholog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein KIAA0513 homolog isoform X3
uncharacterized protein KIAA0513 homolog isoform X1
KIAA0513 ortholog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
KIAA0513 ortholog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein KIAA0513 homolog isoform X2
WD repeat-containing protein 88-like, transcript variant X1
WD repeat-containing protein 88-like, transcript variant X2
WD repeat-containing protein 88-like isoform X1
WD repeat-containing protein 88-like isoform X2
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
low-density lipoprotein receptor-related protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
low-density lipoprotein receptor-related protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 3-like isoform X1
low-density lipoprotein receptor-related protein 3-like isoform X2
low-density lipoprotein receptor-related protein 3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
CCAAT enhancer binding protein gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
CCAAT enhancer binding protein gamma, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CCAAT enhancer binding protein gamma, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CCAAT enhancer binding protein gamma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
transcription initiation factor TFIID subunit 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription initiation factor TFIID subunit 4-like isoform X1
transcription initiation factor TFIID subunit 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription initiation factor TFIID subunit 4-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcription initiation factor TFIID subunit 4B-like isoform X6
transcription initiation factor TFIID subunit 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription initiation factor TFIID subunit 4-like, transcript variant X6
transcription initiation factor TFIID subunit 4-like isoform X4
transcription initiation factor TFIID subunit 4B-like isoform X5
transcription initiation factor TFIID subunit 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcription initiation factor TFIID subunit 4-like, transcript variant X2
transcription initiation factor TFIID subunit 4-like isoform X3
transcription initiation factor TFIID subunit 4-like isoform X2
protein LSM14 homolog A-like, transcript variant X2
protein LSM14 homolog A-like, transcript variant X4
protein LSM14 homolog A-like, transcript variant X1
protein LSM14 homolog A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquitin-like modifier activating enzyme 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ubiquitin-like modifier activating enzyme 2, transcript variant X1
SUMO-activating enzyme subunit 2 isoform X1
ubiquitin-like modifier activating enzyme 2, transcript variant X3
SUMO-activating enzyme subunit 2 isoform X2
Wilms tumor protein 1-interacting protein homolog
granule associated Rac and RHOG effector protein 1-like, transcript variant X1
granule associated Rac and RHOG effector protein 1-like, transcript variant X5
granule associated Rac and RHOG effector protein 1-like, transcript variant X4
granule associated Rac and RHOG effector protein 1-like, transcript variant X2
granule associated Rac and RHOG effector protein 1-like, transcript variant X3
granule associated Rac and RHOG effector protein 1-like isoform X1
granule associated Rac and RHOG effector protein 1-like isoform X2
programmed cell death 2-like, transcript variant X2
programmed cell death 2-like, transcript variant X1
programmed cell death protein 2-like isoform X1
programmed cell death protein 2-like isoform X2
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00096
fatty acyl-CoA hydrolase precursor, medium chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122558658, transcript variant X1
uncharacterized LOC122558658, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cytosolic iron-sulfur assembly component 2B, transcript variant X1
cytosolic iron-sulfur assembly component 2B, transcript variant X2
cytosolic iron-sulfur assembly component 2B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
nedd8 activating enzyme E1 subunit 1, transcript variant X2
nedd8 activating enzyme E1 subunit 1, transcript variant X1
NEDD8-activating enzyme E1 regulatory subunit isoform X1
NEDD8-activating enzyme E1 regulatory subunit isoform X2
telomere repeat binding bouquet formation protein 1
telomere repeats-binding bouquet formation protein 1
dynein, cytoplasmic 1, light intermediate chain 2
cytoplasmic dynein 1 light intermediate chain 2
CKLF-like MARVEL transmembrane domain containing 4
CKLF-like MARVEL transmembrane domain-containing protein 4
CKLF-like MARVEL transmembrane domain containing 3
CKLF-like MARVEL transmembrane domain-containing protein 3
thymidine kinase 2, transcript variant X2
thymidine kinase 2, transcript variant X1
thymidine kinase 2, mitochondrial isoform X1
thymidine kinase 2, mitochondrial isoform X2
thymidine kinase 2, transcript variant X3
thymidine kinase 2, mitochondrial isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized protein si:ch211-189a15.5
brain expressed, associated with NEDD4, 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cadherin 11, type 2, OB-cadherin (osteoblast), transcript variant X4
cadherin 11, type 2, OB-cadherin (osteoblast), transcript variant X1
cadherin 11, type 2, OB-cadherin (osteoblast), transcript variant X3
cadherin 11, type 2, OB-cadherin (osteoblast), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122558661, transcript variant X1
uncharacterized LOC122558661, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
ADAM metallopeptidase with thrombospondin type 1 motif, 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif, 18, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 18
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X1
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X3
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X2
peroxisomal coenzyme A diphosphatase NUDT7-like isoform X1
hypoxanthine-guanine phosphoribosyltransferase-like isoform X2
hypoxanthine-guanine phosphoribosyltransferase-like isoform X3
synaptic vesicle membrane protein VAT-1 homolog-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized si:dkey-234i14.6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized si:dkey-234i14.6, transcript variant X1
uncharacterized protein si:dkey-234i14.6 isoform X1
uncharacterized protein si:dkey-234i14.6 isoform X2
uncharacterized LOC122558663, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122558663, transcript variant X2
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog a (paralog a), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog a (paralog a), transcript variant X4
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog a (paralog a), transcript variant X3
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog a (paralog a), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog a (paralog a), transcript variant X5
uncharacterized LOC122558227, transcript variant X3
uncharacterized LOC122558227, transcript variant X2
uncharacterized LOC122558227, transcript variant X1
WW domain containing oxidoreductase, transcript variant X1
WW domain containing oxidoreductase, transcript variant X4
WW domain containing oxidoreductase, transcript variant X7
WW domain containing oxidoreductase, transcript variant X3
WW domain-containing oxidoreductase isoform X7
WW domain-containing oxidoreductase isoform X3
WW domain-containing oxidoreductase isoform X4
WW domain-containing oxidoreductase isoform X1
WW domain containing oxidoreductase, transcript variant X2
WW domain containing oxidoreductase, transcript variant X5
WW domain-containing oxidoreductase isoform X5
WW domain-containing oxidoreductase isoform X2
WW domain containing oxidoreductase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WW domain-containing oxidoreductase isoform X6
WW domain containing oxidoreductase, transcript variant X10
WW domain-containing oxidoreductase isoform X10
WW domain containing oxidoreductase, transcript variant X9
WW domain-containing oxidoreductase isoform X9
WW domain containing oxidoreductase, transcript variant X8
WW domain-containing oxidoreductase isoform X8
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chromodomain Y-like protein 2, transcript variant X1
chromodomain Y-like protein 2, transcript variant X2
chromodomain Y-like protein 2 isoform X1
chromodomain Y-like protein 2 isoform X2
C-x(9)-C motif containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
C-x(9)-C motif containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
C-x(9)-C motif containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C-x(9)-C motif containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
COX assembly mitochondrial protein 2 homolog
centromere protein N, transcript variant X1
centromere protein N, transcript variant X2
centromere protein N, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
M-phase specific PLK1 interacting protein
M-phase-specific PLK1-interacting protein
protein phosphatase 1 regulatory subunit 3E
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CBY1-interacting BAR domain-containing protein 2-like, transcript variant X5
CBY1-interacting BAR domain-containing protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CBY1-interacting BAR domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CBY1-interacting BAR domain-containing protein 2-like, transcript variant X4
CBY1-interacting BAR domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CBY1-interacting BAR domain-containing protein 2-like isoform X5
CBY1-interacting BAR domain-containing protein 2-like isoform X3
CBY1-interacting BAR domain-containing protein 2-like isoform X2
CBY1-interacting BAR domain-containing protein 2-like isoform X4
CBY1-interacting BAR domain-containing protein 2-like isoform X1
Gse1 coiled-coil protein b, transcript variant X1
Gse1 coiled-coil protein b, transcript variant X2
Gse1 coiled-coil protein b, transcript variant X3
Gse1 coiled-coil protein b, transcript variant X6
Gse1 coiled-coil protein b, transcript variant X7
Gse1 coiled-coil protein b, transcript variant X5
Gse1 coiled-coil protein b, transcript variant X10
Gse1 coiled-coil protein b, transcript variant X4
Gse1 coiled-coil protein b, transcript variant X8
Gse1 coiled-coil protein b, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
DNA replication complex GINS protein PSF2
uncharacterized LOC122558243, transcript variant X2
uncharacterized LOC122558243, transcript variant X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X5
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X3
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X4
cytochrome c oxidase subunit 4 isoform 1, mitochondrial isoform X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X7
cytochrome c oxidase subunit 4 isoform 1, mitochondrial isoform X5
cytochrome c oxidase subunit 4 isoform 1, mitochondrial isoform X4
cytochrome c oxidase subunit 4 isoform 1, mitochondrial isoform X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial isoform X3
dual specificity protein phosphatase 22-A
interferon regulatory factor 8, transcript variant X2
interferon regulatory factor 8, transcript variant X1
interferon regulatory factor 8 isoform X1
interferon regulatory factor 8 isoform X2
uncharacterized LOC122558667, transcript variant X1
uncharacterized LOC122558667, transcript variant X2
methenyltetrahydrofolate synthetase domain containing, transcript variant X3
methenyltetrahydrofolate synthetase domain containing, transcript variant X4
methenyltetrahydrofolate synthetase domain containing, transcript variant X1
methenyltetrahydrofolate synthetase domain containing, transcript variant X2
methenyltetrahydrofolate synthase domain-containing protein isoform X3
methenyltetrahydrofolate synthase domain-containing protein isoform X4
methenyltetrahydrofolate synthase domain-containing protein isoform X1
methenyltetrahydrofolate synthase domain-containing protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized phosphotransferase YvkC-like, transcript variant X2
uncharacterized phosphotransferase YvkC-like, transcript variant X3
uncharacterized phosphotransferase YvkC-like, transcript variant X4
uncharacterized phosphotransferase YvkC-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
putative phosphoenolpyruvate synthase isoform X2
putative phosphoenolpyruvate synthase isoform X1
putative phosphoenolpyruvate synthase isoform X3
uncharacterized phosphotransferase YvkC-like isoform X4
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122558252, transcript variant X2
uncharacterized LOC122558252, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X3
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X4
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X5
hepatocyte nuclear factor 4-beta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hepatocyte nuclear factor 4-beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hepatocyte nuclear factor 4-beta-like isoform X1
hepatocyte nuclear factor 4-beta-like isoform X2
cysteine-rich secretory protein LCCL domain containing 2
cysteine-rich secretory protein LCCL domain-containing 2
ubiquitin carboxyl-terminal hydrolase 10
kelch-like family member 36, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
kelch-like family member 36, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
coactosin-like F-actin binding protein 1
MTOR associated protein, eak-7 homolog, transcript variant X3
MTOR associated protein, eak-7 homolog, transcript variant X1
MTOR associated protein, eak-7 homolog, transcript variant X2
calcium-transporting ATPase type 2C member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
WAP four-disulfide core domain protein 1
potassium voltage-gated channel, subfamily G, member 4a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel, subfamily G, member 4a, transcript variant X2
potassium voltage-gated channel subfamily G member 4a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
malonyl-CoA decarboxylase, mitochondrial
cadherin 13, H-cadherin (heart), transcript variant X1
cadherin 13, H-cadherin (heart), transcript variant X2
hydroxysteroid (17-beta) dehydrogenase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X5
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X1
short-chain dehydrogenase/reductase family 42E member 1 isoform X2
short-chain dehydrogenase/reductase family 42E member 1 isoform X3
short-chain dehydrogenase/reductase family 42E member 1 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
c-Maf inducing protein, transcript variant X2
c-Maf inducing protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glycine cleavage system H protein, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: polycystic kidney disease protein 1-like 2
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
beta,beta-carotene 15,15'-dioxygenase-like
spermatogenesis associated 2-like, transcript variant X1
spermatogenesis associated 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized protein LOC560780 homolog
uncharacterized protein si:dkey-238o13.4
VPS9 domain containing 1, transcript variant X1
VPS9 domain-containing protein 1 isoform X1
VPS9 domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
VPS9 domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
VPS9 domain-containing protein 1 isoform X2
VPS9 domain containing 1, transcript variant X5
VPS9 domain-containing protein 1 isoform X4
VPS9 domain containing 1, transcript variant X4
VPS9 domain-containing protein 1 isoform X3
uncharacterized LOC122558285, transcript variant X1
uncharacterized LOC122558285, transcript variant X2
zinc finger homeobox 3b, transcript variant X3
zinc finger homeobox 3b, transcript variant X5
zinc finger homeobox 3b, transcript variant X2
zinc finger homeobox 3b, transcript variant X1
zinc finger homeobox 3b, transcript variant X4
zinc finger homeobox 3b, transcript variant X6
zinc finger homeobox protein 3 isoform X1
zinc finger homeobox protein 3 isoform X2
uncharacterized LOC122558287, transcript variant X2
uncharacterized LOC122558287, transcript variant X1
polyamine-modulated factor 1-binding protein 1, transcript variant X1
polyamine-modulated factor 1-binding protein 1 isoform X1
polyamine-modulated factor 1-binding protein 1, transcript variant X2
polyamine-modulated factor 1-binding protein 1, transcript variant X4
polyamine-modulated factor 1-binding protein 1 isoform X2
polyamine-modulated factor 1-binding protein 1, transcript variant X3
polyamine-modulated factor 1-binding protein 1 isoform X4
polyamine-modulated factor 1-binding protein 1 isoform X3
polyamine-modulated factor 1-binding protein 1, transcript variant X5
polyamine-modulated factor 1-binding protein 1, transcript variant X6
polyamine-modulated factor 1-binding protein 1 isoform X5
DEAH (Asp-Glu-Ala-His) box polypeptide 38
pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16
26S proteasome non-ATPase regulatory subunit 7
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X3
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X2
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X1
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X2
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X1
NEDD4-like E3 ubiquitin-protein ligase WWP2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
transmembrane emp24 domain-containing protein 6
telomeric repeat-binding factor 2-like, transcript variant X4
telomeric repeat-binding factor 2-like, transcript variant X3
telomeric repeat-binding factor 2-like, transcript variant X2
telomeric repeat-binding factor 2-like, transcript variant X1
telomeric repeat-binding factor 2-like isoform X2
telomeric repeat-binding factor 2-like isoform X4
telomeric repeat-binding factor 2-like isoform X3
telomeric repeat-binding factor 2-like isoform X1
nuclear factor of activated T-cells 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
lysyl-tRNA synthetase 1, transcript variant X2
lysyl-tRNA synthetase 1, transcript variant X1
adenosine deaminase tRNA specific 1, transcript variant X3
adenosine deaminase tRNA specific 1, transcript variant X4
adenosine deaminase tRNA specific 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
adenosine deaminase tRNA specific 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
tRNA-specific adenosine deaminase 1 isoform X1
tRNA-specific adenosine deaminase 1 isoform X2
adenosine deaminase tRNA specific 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tRNA-specific adenosine deaminase 1 isoform X3
GABA(A) receptor-associated protein like 2
gamma-aminobutyric acid receptor-associated protein-like 2
transmembrane protein 231, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 231, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane protein 231, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
IST1 factor associated with ESCRT-III, transcript variant X1
IST1 factor associated with ESCRT-III, transcript variant X4
IST1 factor associated with ESCRT-III, transcript variant X2
IST1 factor associated with ESCRT-III, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
IST1 factor associated with ESCRT-III, transcript variant X3
polycystic kidney disease protein 1-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
dihydroorotate dehydrogenase, transcript variant X1
dihydroorotate dehydrogenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
dihydroorotate dehydrogenase (quinone), mitochondrial isoform X1
dihydroorotate dehydrogenase (quinone), mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
conserved oligomeric Golgi complex subunit 8
NIN1 (RPN12) binding protein 1 homolog, transcript variant X2
NIN1 (RPN12) binding protein 1 homolog, transcript variant X1
NIN1 (RPN12) binding protein 1 homolog, transcript variant X3
zinc finger protein 821-like, transcript variant X4
zinc finger protein 821-like, transcript variant X3
zinc finger protein 821-like, transcript variant X2
zinc finger protein 821-like, transcript variant X1
chromatin licensing and DNA replication factor 1
piezo-type mechanosensitive ion channel component 1
cytosolic thiouridylase subunit 2 homolog (S. pombe), transcript variant X3
cytosolic thiouridylase subunit 2 homolog (S. pombe), transcript variant X2
cytosolic thiouridylase subunit 2 homolog (S. pombe), transcript variant X1
cytosolic thiouridylase subunit 2 homolog (S. pombe), transcript variant X4
cytoplasmic tRNA 2-thiolation protein 2 isoform X2
cytoplasmic tRNA 2-thiolation protein 2 isoform X1
cytoplasmic tRNA 2-thiolation protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
snail family zinc finger 3, transcript variant X1
snail family zinc finger 3, transcript variant X2
mevalonate (diphospho) decarboxylase a, transcript variant X1
mevalonate (diphospho) decarboxylase a, transcript variant X10
mevalonate (diphospho) decarboxylase a, transcript variant X9
mevalonate (diphospho) decarboxylase a, transcript variant X11
mevalonate (diphospho) decarboxylase a, transcript variant X5
mevalonate (diphospho) decarboxylase a, transcript variant X8
mevalonate (diphospho) decarboxylase a, transcript variant X2
mevalonate (diphospho) decarboxylase a, transcript variant X3
mevalonate (diphospho) decarboxylase a, transcript variant X7
mevalonate (diphospho) decarboxylase a, transcript variant X4
mevalonate (diphospho) decarboxylase a, transcript variant X6
diphosphomevalonate decarboxylase isoform X1
diphosphomevalonate decarboxylase isoform X3
diphosphomevalonate decarboxylase isoform X4
diphosphomevalonate decarboxylase isoform X2
diphosphomevalonate decarboxylase isoform X6
diphosphomevalonate decarboxylase isoform X5
diphosphomevalonate decarboxylase isoform X7
diphosphomevalonate decarboxylase isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
dysbindin domain containing 1, transcript variant X3
dysbindin domain containing 1, transcript variant X2
dysbindin domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
differentially expressed in FDCP 8 homolog, transcript variant X2
differentially expressed in FDCP 8 homolog, transcript variant X1
differentially expressed in FDCP 8 homolog, transcript variant X3
differentially expressed in FDCP 8 homolog isoform X2
differentially expressed in FDCP 8 homolog isoform X1
differentially expressed in FDCP 8 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins
solute carrier family 22 member 31, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 22 member 31, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative solute carrier family 22 member 31 isoform X2
putative solute carrier family 22 member 31 isoform X1
ankyrin repeat domain 11, transcript variant X1
ankyrin repeat domain 11, transcript variant X3
ankyrin repeat domain 11, transcript variant X2
ankyrin repeat domain 11, transcript variant X5
ankyrin repeat domain-containing protein 11 isoform X1
ankyrin repeat domain-containing protein 11 isoform X3
ankyrin repeat domain 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ankyrin repeat domain-containing protein 11 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
SPG7 matrix AAA peptidase subunit, paraplegin
COORDINATES: nucleotide motif:Rfam:12.0:RF00324
uncharacterized protein LOC561993 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
NIP7 nucleolar pre-rRNA processing protein
60S ribosome subunit biogenesis protein NIP7 homolog
Fanconi anemia group A protein-like, transcript variant X4
Fanconi anemia group A protein-like, transcript variant X3
Fanconi anemia group A protein-like, transcript variant X1
Fanconi anemia group A protein-like, transcript variant X5
Fanconi anemia group A protein-like, transcript variant X2
Fanconi anemia group A protein-like, transcript variant X6
Fanconi anemia group A protein-like, transcript variant X8
Fanconi anemia group A protein-like, transcript variant X7
Fanconi anemia group A protein-like isoform X2
Fanconi anemia group A protein-like isoform X1
Fanconi anemia group A protein-like isoform X3
Fanconi anemia group A protein-like isoform X5
Fanconi anemia group A protein-like isoform X6
Fanconi anemia group A protein-like isoform X4
spire-type actin nucleation factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
spire-type actin nucleation factor 2, transcript variant X1
spire-type actin nucleation factor 2, transcript variant X2
transcription factor 25 (basic helix-loop-helix), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transcription factor 25 (basic helix-loop-helix), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
zinc finger protein, FOG family member 1
uncharacterized LOC122558346, transcript variant X1
uncharacterized LOC122558346, transcript variant X2
thyrotropin-releasing hormone receptor-like
microtubule-associated proteins 1A/1B light chain 3B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
BTG3 associated nuclear protein, transcript variant X2
BTG3 associated nuclear protein, transcript variant X3
BTG3 associated nuclear protein, transcript variant X1
BTG3 associated nuclear protein, transcript variant X4
carbonic anhydrase Va, transcript variant X2
carbonic anhydrase Va, transcript variant X1
carbonic anhydrase 5A, mitochondrial isoform X1
carbonic anhydrase 5A, mitochondrial isoform X2
large neutral amino acids transporter small subunit 1
kelch domain containing 4, transcript variant X2
kelch domain-containing protein 4 isoform X2
kelch domain containing 4, transcript variant X1
kelch domain-containing protein 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC378987 homolog, transcript variant X2
uncharacterized protein LOC378987 homolog, transcript variant X1
uncharacterized protein LOC378987 homolog, transcript variant X3
flavin-containing monooxygenase FMO GS-OX-like 5 isoform X1
flavin-containing monooxygenase FMO GS-OX-like 5 isoform X2
zinc finger CCHC domain-containing protein 14
adaptor related protein complex 1 subunit gamma 1, transcript variant X1
adaptor related protein complex 1 subunit gamma 1, transcript variant X3
adaptor related protein complex 1 subunit gamma 1, transcript variant X2
PH domain leucine-rich repeat-containing protein phosphatase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MARVEL domain-containing protein 3-like, transcript variant X2
MARVEL domain-containing protein 3-like isoform X2
MARVEL domain-containing protein 3-like, transcript variant X3
MARVEL domain-containing protein 3-like isoform X3
MARVEL domain-containing protein 3-like, transcript variant X1
MARVEL domain-containing protein 3-like isoform X1
MARVEL domain-containing protein 3-like, transcript variant X4
uncharacterized protein LOC100073327 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100073327 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100073327 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100073327 homolog, transcript variant X5
uncharacterized protein LOC100073327 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100073327 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100073327 homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC100073327 homolog, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC100073327 homolog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
putative ATP-dependent RNA helicase TDRD12
regulator of G-protein signaling 9-binding protein
ankyrin repeat domain-containing protein 27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122558362, transcript variant X1
uncharacterized LOC122558362, transcript variant X2
zinc finger protein 507, transcript variant X3
zinc finger protein 507, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 507, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
uncharacterized LOC122558367, transcript variant X2
uncharacterized LOC122558367, transcript variant X1
uncharacterized LOC122558366, transcript variant X2
uncharacterized LOC122558366, transcript variant X1
teashirt zinc finger homeobox 3b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
teashirt zinc finger homeobox 3b, transcript variant X1
teashirt zinc finger homeobox 3b, transcript variant X2
zinc finger protein 536, transcript variant X4
zinc finger protein 536, transcript variant X2
zinc finger protein 536, transcript variant X7
zinc finger protein 536, transcript variant X6
zinc finger protein 536, transcript variant X1
zinc finger protein 536, transcript variant X3
zinc finger protein 536, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger protein 536, transcript variant X5
zinc finger protein 536, transcript variant X10
zinc finger protein 536, transcript variant X11
zinc finger protein 536, transcript variant X9
zinc finger protein 536, transcript variant X12
URI1 prefoldin like chaperone, transcript variant X2
URI1 prefoldin like chaperone, transcript variant X1
unconventional prefoldin RPB5 interactor 1 isoform X2
unconventional prefoldin RPB5 interactor 1 isoform X1
uncharacterized protein LOC555865 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC555865 homolog, transcript variant X3
uncharacterized protein F13E9.13, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC555865 homolog, transcript variant X5
uncharacterized protein LOC555865 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized protein LOC555865 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein F13E9.13, mitochondrial isoform X3
uncharacterized protein F13E9.13, mitochondrial isoform X4
uncharacterized protein F13E9.13, mitochondrial isoform X1
uncharacterized protein LOC555795 homolog, transcript variant X3
uncharacterized protein si:ch211-260e23.9 isoform X2
uncharacterized protein LOC555795 homolog, transcript variant X4
uncharacterized protein si:ch211-260e23.9 isoform X3
uncharacterized protein LOC555795 homolog, transcript variant X2
uncharacterized protein LOC555795 homolog, transcript variant X1
uncharacterized protein si:ch211-260e23.9 isoform X1
protein C19orf12 homolog, transcript variant X1
protein C19orf12 homolog, transcript variant X2
pleckstrin homology domain containing, family F (with FYVE domain) member 1, transcript variant X3
pleckstrin homology domain containing, family F (with FYVE domain) member 1, transcript variant X4
pleckstrin homology domain containing, family F (with FYVE domain) member 1, transcript variant X1
pleckstrin homology domain containing, family F (with FYVE domain) member 1, transcript variant X2
pleckstrin homology domain-containing family F member 1 isoform X1
pleckstrin homology domain-containing family F member 1 isoform X2
pleckstrin homology domain-containing family F member 1 isoform X3
NLR family CARD domain-containing protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NLR family CARD domain-containing protein 3-like, transcript variant X1
NLR family CARD domain-containing protein 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NLR family CARD domain-containing protein 3-like, transcript variant X3
NLR family CARD domain-containing protein 3-like isoform X1
NLR family CARD domain-containing protein 3-like isoform X3
NLR family CARD domain-containing protein 3-like isoform X2
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X2
POP4 homolog, ribonuclease P/MRP subunit, transcript variant X1
ribonuclease P protein subunit p29 isoform X2
ribonuclease P protein subunit p29 isoform X1
V-set and transmembrane domain containing 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
V-set and transmembrane domain-containing protein 2B isoform X2
V-set and transmembrane domain containing 2B, transcript variant X1
V-set and transmembrane domain-containing protein 2B isoform X1
cytochrome b-c1 complex subunit Rieske, mitochondrial
SHC SH2-domain binding protein 1, transcript variant X2
SHC SH2-domain binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SHC SH2-domain binding protein 1, transcript variant X3
SHC SH2 domain-binding protein 1 isoform X2
SHC SH2 domain-binding protein 1 isoform X1
SHC SH2 domain-binding protein 1 isoform X3
VPS35 retromer complex component, transcript variant X1
VPS35 retromer complex component, transcript variant X2
vacuolar protein sorting-associated protein 35 isoform X1
vacuolar protein sorting-associated protein 35 isoform X2
origin recognition complex, subunit 6, transcript variant X3
origin recognition complex, subunit 6, transcript variant X1
origin recognition complex, subunit 6, transcript variant X2
origin recognition complex subunit 6 isoform X1
origin recognition complex subunit 6 isoform X2
myosin light chain kinase 3, transcript variant X2
myosin light chain kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
chromosome 17 C16orf87 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
UPF0547 protein C16orf87 homolog isoform X4
chromosome 17 C16orf87 homolog, transcript variant X6
chromosome 17 C16orf87 homolog, transcript variant X5
chromosome 17 C16orf87 homolog, transcript variant X1
chromosome 17 C16orf87 homolog, transcript variant X3
UPF0547 protein C16orf87 homolog isoform X6
UPF0547 protein C16orf87 homolog isoform X5
UPF0547 protein C16orf87 homolog isoform X3
UPF0547 protein C16orf87 homolog isoform X1
chromosome 17 C16orf87 homolog, transcript variant X2
UPF0547 protein C16orf87 homolog isoform X2
glutamic pyruvate transaminase (alanine aminotransferase) 2, transcript variant X2
glutamic pyruvate transaminase (alanine aminotransferase) 2, transcript variant X1
DnaJ heat shock protein family (Hsp40) member A2a
neuropilin and tolloid-like protein 2, transcript variant X1
neuropilin and tolloid-like protein 2, transcript variant X2
neuropilin and tolloid-like protein 2, transcript variant X3
neuropilin and tolloid-like protein 2, transcript variant X4
neuropilin and tolloid-like protein 2 isoform X3
neuropilin and tolloid-like protein 2 isoform X1
neuropilin and tolloid-like protein 2 isoform X4
neuropilin and tolloid-like protein 2 isoform X2
integrin alpha FG-GAP repeat containing 1
phosphorylase kinase, beta, transcript variant X1
phosphorylase b kinase regulatory subunit beta isoform X1
phosphorylase kinase, beta, transcript variant X2
phosphorylase kinase, beta, transcript variant X3
phosphorylase b kinase regulatory subunit beta isoform X2
ATP-binding cassette, sub-family C (CFTR/MRP), member 12, transcript variant X3
ATP-binding cassette, sub-family C (CFTR/MRP), member 12, transcript variant X1
ATP-binding cassette, sub-family C (CFTR/MRP), member 12, transcript variant X2
ATP-binding cassette sub-family C member 12 isoform X2
ATP-binding cassette sub-family C member 12 isoform X1
siah E3 ubiquitin protein ligase 1, transcript variant X1
siah E3 ubiquitin protein ligase 1, transcript variant X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized protein LOC492735 homolog, transcript variant X2
uncharacterized protein LOC492735 homolog, transcript variant X1
plasmanylethanolamine desaturase isoform X2
plasmanylethanolamine desaturase isoform X1
zinc finger protein 423, transcript variant X6
zinc finger protein 423, transcript variant X3
zinc finger protein 423, transcript variant X2
zinc finger protein 423, transcript variant X4
zinc finger protein 423, transcript variant X1
zinc finger protein 423, transcript variant X5
nuclear receptor coactivator 5-like, transcript variant X3
nuclear receptor coactivator 5-like, transcript variant X1
nuclear receptor coactivator 5-like, transcript variant X2
nuclear receptor coactivator 5-like isoform X2
nuclear receptor coactivator 5-like isoform X1
CTD nuclear envelope phosphatase 1 regulatory subunit 1
nuclear envelope phosphatase-regulatory subunit 1
HEAT repeat containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
HEAT repeat containing 3, transcript variant X1
HEAT repeat containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
HEAT repeat-containing protein 3 isoform X1
HEAT repeat-containing protein 3 isoform X2
HEAT repeat-containing protein 3 isoform X3
terminal nucleotidyltransferase 4B, transcript variant X1
terminal nucleotidyltransferase 4B, transcript variant X2
adenylate cyclase 7, transcript variant X1
adenylate cyclase 7, transcript variant X3
adenylate cyclase 7, transcript variant X4
adenylate cyclase 7, transcript variant X2
adenylate cyclase 7, transcript variant X5
bromodomain containing 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
bromodomain containing 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
bromodomain-containing protein 7 isoform X2
bromodomain-containing protein 7 isoform X1
NKD inhibitor of WNT signaling pathway 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
NKD inhibitor of WNT signaling pathway 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein naked cuticle homolog 1 isoform X1
protein naked cuticle homolog 1 isoform X2
NKD inhibitor of WNT signaling pathway 1, transcript variant X3
protein naked cuticle homolog 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nucleotide-binding oligomerization domain containing 2, transcript variant X1
nucleotide-binding oligomerization domain containing 2, transcript variant X3
nucleotide-binding oligomerization domain containing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nucleotide-binding oligomerization domain containing 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleotide-binding oligomerization domain containing 2, transcript variant X4
nucleotide-binding oligomerization domain containing 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nucleotide-binding oligomerization domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nucleotide-binding oligomerization domain containing 2, transcript variant X2
nucleotide-binding oligomerization domain-containing protein 2 isoform X1
nucleotide-binding oligomerization domain-containing protein 2 isoform X2
nucleotide-binding oligomerization domain-containing protein 2 isoform X3
nucleotide-binding oligomerization domain-containing protein 2 isoform X4
cylindromatosis (turban tumor syndrome), a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase CYLD
uncharacterized LOC122558419, transcript variant X2
uncharacterized LOC122558419, transcript variant X1
TOX high mobility group box family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TOX high mobility group box family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TOX high mobility group box family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
TOX high mobility group box family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TOX high mobility group box family member 3 isoform X3
TOX high mobility group box family member 3 isoform X2
TOX high mobility group box family member 3 isoform X1
TOX high mobility group box family member 3 isoform X4
uncharacterized LOC122558678, transcript variant X2
uncharacterized LOC122558678, transcript variant X1
chromodomain helicase DNA binding protein 9, transcript variant X3
chromodomain helicase DNA binding protein 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
chromodomain helicase DNA binding protein 9, transcript variant X2
chromodomain helicase DNA binding protein 9, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 9 isoform X1
chromodomain-helicase-DNA-binding protein 9 isoform X3
chromodomain-helicase-DNA-binding protein 9 isoform X2
chromodomain helicase DNA binding protein 9, transcript variant X4
chromodomain-helicase-DNA-binding protein 9 isoform X4
chromodomain helicase DNA binding protein 9, transcript variant X5
chromodomain-helicase-DNA-binding protein 9 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
akt interacting protein, transcript variant X1
akt interacting protein, transcript variant X2
akt interacting protein, transcript variant X4
akt interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X4
alpha-ketoglutarate-dependent dioxygenase FTO isoform X4
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X3
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X7
alpha-ketoglutarate-dependent dioxygenase FTO isoform X3
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X1
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X2
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X5
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X6
alpha-ketoglutarate-dependent dioxygenase FTO isoform X2
alpha-ketoglutarate-dependent dioxygenase FTO isoform X6
alpha-ketoglutarate-dependent dioxygenase FTO isoform X1
alpha-ketoglutarate-dependent dioxygenase FTO isoform X5
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X8
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X9
alpha-ketoglutarate-dependent dioxygenase FTO isoform X7
iroquois-class homeodomain protein IRX-3a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC122558432, transcript variant X2
uncharacterized LOC122558432, transcript variant X1
uncharacterized LOC122558431, transcript variant X7
uncharacterized LOC122558431, transcript variant X1
uncharacterized LOC122558431, transcript variant X6
uncharacterized LOC122558431, transcript variant X3
uncharacterized LOC122558431, transcript variant X2
uncharacterized LOC122558431, transcript variant X4
uncharacterized LOC122558431, transcript variant X5
uncharacterized LOC122558431, transcript variant X8
iroquois-class homeodomain protein IRX-5a
uncharacterized LOC122558434, transcript variant X2
uncharacterized LOC122558434, transcript variant X1
iroquois homeobox 6a, transcript variant X3
iroquois-class homeodomain protein IRX-6a isoform X3
iroquois homeobox 6a, transcript variant X4
iroquois-class homeodomain protein IRX-6a isoform X4
iroquois homeobox 6a, transcript variant X1
iroquois homeobox 6a, transcript variant X2
iroquois-class homeodomain protein IRX-6a isoform X1
iroquois-class homeodomain protein IRX-6a isoform X2
lysophosphatidylcholine acyltransferase 2
solute carrier family 6 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium-dependent noradrenaline transporter isoform X1
solute carrier family 6 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium-dependent noradrenaline transporter isoform X2
solute carrier family 6 member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-dependent noradrenaline transporter isoform X3
solute carrier family 12 member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 12 member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
galanin receptor 1b, transcript variant X1
galanin receptor 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
galanin receptor 1b, transcript variant X3
DEAD (Asp-Glu-Ala-Asp) box polypeptide 28
probable ATP-dependent RNA helicase DDX28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like
nuclear factor of activated T cells 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear factor of activated T cells 3a, transcript variant X2
nuclear factor of activated T-cells, cytoplasmic 3 isoform X2
nuclear factor of activated T-cells, cytoplasmic 3 isoform X1
nuclear factor of activated T cells 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 3 isoform X3
uncharacterized LOC122558679, transcript variant X2
uncharacterized LOC122558679, transcript variant X1
epithelial splicing regulatory protein 2
uncharacterized LOC122558448, transcript variant X2
uncharacterized LOC122558448, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
C3a anaphylatoxin chemotactic receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
BCAR1 scaffold protein, Cas family member, transcript variant X3
breast cancer anti-estrogen resistance protein 1 isoform X3
BCAR1 scaffold protein, Cas family member, transcript variant X2
breast cancer anti-estrogen resistance protein 1 isoform X2
BCAR1 scaffold protein, Cas family member, transcript variant X1
breast cancer anti-estrogen resistance protein 1 isoform X1
craniofacial development protein 1, transcript variant X2
craniofacial development protein 1, transcript variant X1
craniofacial development protein 1 isoform X2
craniofacial development protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
VRK serine/threonine kinase 3, transcript variant X3
VRK serine/threonine kinase 3, transcript variant X2
VRK serine/threonine kinase 3, transcript variant X1
VRK serine/threonine kinase 3, transcript variant X4
VRK serine/threonine kinase 3, transcript variant X5
inactive serine/threonine-protein kinase VRK3
RHO family interacting cell polarization regulator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
RHO family interacting cell polarization regulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho family-interacting cell polarization regulator 1 isoform X1
RHO family interacting cell polarization regulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
rho family-interacting cell polarization regulator 1 isoform X2
RHO family interacting cell polarization regulator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
rho family-interacting cell polarization regulator 1 isoform X3
CCCTC-binding factor (zinc finger protein), transcript variant X2
CCCTC-binding factor (zinc finger protein), transcript variant X3
CCCTC-binding factor (zinc finger protein), transcript variant X1
transcriptional repressor CTCF isoform X1
transcriptional repressor CTCF isoform X2
capping protein regulator and myosin 1 linker 2, transcript variant X3
capping protein regulator and myosin 1 linker 2, transcript variant X1
capping protein regulator and myosin 1 linker 2, transcript variant X2
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X1
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X3
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X2
capping protein regulator and myosin 1 linker 2, transcript variant X4
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X4
uncharacterized LOC122558458, transcript variant X2
uncharacterized LOC122558458, transcript variant X1
uncharacterized protein LOC122558458 isoform X2
uncharacterized protein LOC122558458 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
par-6 family cell polarity regulator alpha
glucose-fructose oxidoreductase domain-containing protein 2-like, transcript variant X2
glucose-fructose oxidoreductase domain-containing protein 2-like, transcript variant X1
glucose-fructose oxidoreductase domain-containing protein 2-like, transcript variant X3
glucose-fructose oxidoreductase domain-containing protein 2-like, transcript variant X4
glucose-fructose oxidoreductase domain-containing protein 2-like
RAN binding protein 10, transcript variant X1
RAN binding protein 10, transcript variant X2
translin-associated factor X interacting protein 1, transcript variant X5
translin-associated factor X interacting protein 1, transcript variant X6
translin-associated factor X interacting protein 1, transcript variant X4
translin-associated factor X interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
translin-associated factor X-interacting protein 1 isoform X1
translin-associated factor X-interacting protein 1 isoform X5
translin-associated factor X-interacting protein 1 isoform X4
translin-associated factor X-interacting protein 1 isoform X6
translin-associated factor X interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
translin-associated factor X-interacting protein 1 isoform X3
translin-associated factor X interacting protein 1, transcript variant X2
translin-associated factor X-interacting protein 1 isoform X2
nuclear transport factor 2, transcript variant X1
nuclear transport factor 2, transcript variant X9
nuclear transport factor 2, transcript variant X8
nuclear transport factor 2, transcript variant X7
nuclear transport factor 2, transcript variant X2
nuclear transport factor 2, transcript variant X3
nuclear transport factor 2, transcript variant X4
nuclear transport factor 2, transcript variant X5
nuclear transport factor 2, transcript variant X6
enhancer of mRNA decapping 4, transcript variant X1
enhancer of mRNA decapping 4, transcript variant X3
enhancer of mRNA decapping 4, transcript variant X2
enhancer of mRNA decapping 4, transcript variant X4
enhancer of mRNA-decapping protein 4 isoform X1
enhancer of mRNA-decapping protein 4 isoform X2
enhancer of mRNA-decapping protein 4 isoform X3
enhancer of mRNA-decapping protein 4 isoform X4
neuritin 1-like a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuritin 1-like a, transcript variant X2
neuritin 1-like a, transcript variant X3
protein serine kinase H1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein serine kinase H1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein serine kinase H1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein kinase H1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 121 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122558474, transcript variant X2
uncharacterized LOC122558474, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
agouti-related protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
agouti-related protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
agouti-related protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
V-type proton ATPase subunit d 1, transcript variant X1
V-type proton ATPase subunit d 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
zinc finger DHHC-type containing 1, transcript variant X1
zinc finger DHHC-type containing 1, transcript variant X3
zinc finger DHHC-type containing 1, transcript variant X2
zinc finger DHHC-type containing 1, transcript variant X5
zinc finger DHHC-type containing 1, transcript variant X4
zinc finger DHHC-type containing 1, transcript variant X6
tubulin polymerization-promoting protein family member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
centrosomal protein of 72 kDa-like, transcript variant X2
centrosomal protein of 72 kDa-like, transcript variant X1
centrosomal protein of 72 kDa-like, transcript variant X4
centrosomal protein of 72 kDa-like, transcript variant X3
leucine-rich repeat-containing protein 36-like isoform X2
centrosomal protein of 72 kDa-like isoform X1
centrosomal protein of 72 kDa-like isoform X4
centrosomal protein of 72 kDa-like isoform X3
BTB/POZ domain-containing protein KCTD19-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology domain containing, family G (with RhoGef domain) member 4, transcript variant X4
pleckstrin homology domain containing, family G (with RhoGef domain) member 4, transcript variant X3
pleckstrin homology domain containing, family G (with RhoGef domain) member 4, transcript variant X1
uncharacterized protein plekhg4 isoform X3
pleckstrin homology domain containing, family G (with RhoGef domain) member 4, transcript variant X2
uncharacterized protein plekhg4 isoform X2
uncharacterized protein plekhg4 isoform X1
solute carrier family 9 member A5, transcript variant X1
solute carrier family 9 member A5, transcript variant X2
formin homology 2 domain containing 1, transcript variant X1
formin homology 2 domain containing 1, transcript variant X3
formin homology 2 domain containing 1, transcript variant X2
FH1/FH2 domain-containing protein 1 isoform X3
FH1/FH2 domain-containing protein 1 isoform X2
FH1/FH2 domain-containing protein 1 isoform X1
transglutaminase 2, like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transglutaminase 2, like, transcript variant X3
transglutaminase 2, like, transcript variant X1
protein-glutamine gamma-glutamyltransferase 2 isoform X2
protein-glutamine gamma-glutamyltransferase 2 isoform X3
protein-glutamine gamma-glutamyltransferase 2 isoform X1
transmembrane protein with metallophosphoesterase domain
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122558491, transcript variant X2
uncharacterized LOC122558491, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized protein LOC122558491 isoform X2
uncharacterized protein LOC122558491 isoform X1
ADP-ribosylation factor-like 2 binding protein, transcript variant X2
ADP-ribosylation factor-like protein 2-binding protein isoform X2
ADP-ribosylation factor-like 2 binding protein, transcript variant X1
ADP-ribosylation factor-like protein 2-binding protein isoform X1
ADP-ribosylation factor-like 2 binding protein, transcript variant X3
ADP-ribosylation factor-like protein 2-binding protein isoform X3
ring finger and SPRY domain containing 1
RING finger and SPRY domain-containing protein 1
proteasome activator subunit 3 interacting protein 1, transcript variant X3
proteasome activator subunit 3 interacting protein 1, transcript variant X1
proteasome activator subunit 3 interacting protein 1, transcript variant X4
proteasome activator subunit 3 interacting protein 1, transcript variant X2
NLR family, CARD domain containing 5, transcript variant X8
NLR family, CARD domain containing 5, transcript variant X6
NLR family, CARD domain containing 5, transcript variant X7
NLR family, CARD domain containing 5, transcript variant X3
NLR family, CARD domain containing 5, transcript variant X9
NLR family, CARD domain containing 5, transcript variant X4
NLR family, CARD domain containing 5, transcript variant X5
NLR family, CARD domain containing 5, transcript variant X1
NLR family, CARD domain containing 5 isoform X3
NLR family, CARD domain containing 5 isoform X7
NLR family, CARD domain containing 5 isoform X4
NLR family, CARD domain containing 5 isoform X1
NLR family, CARD domain containing 5 isoform X6
NLR family, CARD domain containing 5 isoform X5
NLR family, CARD domain containing 5, transcript variant X12
NLR family, CARD domain containing 5, transcript variant X2
NLR family, CARD domain containing 5, transcript variant X11
NLR family, CARD domain containing 5 isoform X2
NLR family, CARD domain containing 5, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cholesteryl ester transfer protein, plasma
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1, transcript variant X2
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1, transcript variant X1
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X2
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 12 member 3
nuclear pore complex protein Nup93 isoform X1
nuclear pore complex protein Nup93 isoform X2
lecithin-cholesterol acyltransferase, transcript variant X2
lecithin-cholesterol acyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphatidylcholine-sterol acyltransferase isoform X2
phosphatidylcholine-sterol acyltransferase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122558509, transcript variant X1
uncharacterized LOC122558509, transcript variant X2
Golgi-associated kinase 1A-like, transcript variant X1
Golgi-associated kinase 1A-like, transcript variant X3
Golgi-associated kinase 1A-like, transcript variant X2
lactate dehydrogenase D, transcript variant X4
lactate dehydrogenase D, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
lactate dehydrogenase D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
lactate dehydrogenase D, transcript variant X1
probable D-lactate dehydrogenase, mitochondrial isoform X1
probable D-lactate dehydrogenase, mitochondrial isoform X3
probable D-lactate dehydrogenase, mitochondrial isoform X2
zinc and ring finger 1, transcript variant X1
E3 ubiquitin-protein ligase znrf1 isoform X1
zinc and ring finger 1, transcript variant X2
E3 ubiquitin-protein ligase znrf1 isoform X2
uncharacterized LOC122558513, transcript variant X1
uncharacterized LOC122558513, transcript variant X2
uncharacterized LOC122558513, transcript variant X3
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pancreatic secretory granule membrane major glycoprotein GP2-like
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X4
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
receptor-interacting serine/threonine-protein kinase 2-like isoform X1
receptor-interacting serine/threonine-protein kinase 2-like isoform X3
receptor-interacting serine/threonine-protein kinase 2-like isoform X4
receptor-interacting serine/threonine-protein kinase 2-like isoform X2
adhesion G-protein coupled receptor G5-like, transcript variant X4
adhesion G-protein coupled receptor G5-like, transcript variant X2
adhesion G-protein coupled receptor G5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adhesion G-protein coupled receptor G5-like, transcript variant X5
adhesion G-protein coupled receptor G5-like, transcript variant X1
adhesion G-protein coupled receptor G5-like isoform X2
adhesion G-protein coupled receptor G5-like isoform X3
adhesion G-protein coupled receptor G5-like isoform X5
adhesion G-protein coupled receptor G5-like isoform X1
adhesion G-protein coupled receptor G5-like isoform X4
uncharacterized LOC122558519, transcript variant X1
uncharacterized LOC122558519, transcript variant X2
adhesion G-protein coupled receptor G2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
membrane-bound transcription factor peptidase, site 1, transcript variant X3
membrane-bound transcription factor peptidase, site 1, transcript variant X2
membrane-bound transcription factor peptidase, site 1, transcript variant X1
membrane-bound transcription factor site-1 protease isoform X3
membrane-bound transcription factor site-1 protease isoform X2
membrane-bound transcription factor site-1 protease isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
F-box and leucine-rich repeat protein 8, transcript variant X1
F-box and leucine-rich repeat protein 8, transcript variant X4
F-box and leucine-rich repeat protein 8, transcript variant X5
F-box and leucine-rich repeat protein 8, transcript variant X2
F-box and leucine-rich repeat protein 8, transcript variant X7
F-box and leucine-rich repeat protein 8, transcript variant X6
F-box and leucine-rich repeat protein 8, transcript variant X3
tumor necrosis factor receptor type 1-associated DEATH domain protein
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O, b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 114 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O, b, transcript variant X2
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O, b isoform X2
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O, b isoform X1
core-binding factor subunit beta, transcript variant X5
core-binding factor subunit beta, transcript variant X6
core-binding factor subunit beta, transcript variant X2
core-binding factor subunit beta, transcript variant X1
core-binding factor subunit beta, transcript variant X4
core-binding factor subunit beta, transcript variant X3
core-binding factor subunit beta isoform X1
core-binding factor subunit beta isoform X3
core-binding factor subunit beta isoform X5
core-binding factor subunit beta isoform X6
core-binding factor subunit beta isoform X2
core-binding factor subunit beta isoform X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X1
sphingomyelin phosphodiesterase 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122558537, transcript variant X1
uncharacterized LOC122558537, transcript variant X2
pyruvate dehydrogenase phosphatase regulatory subunit
pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial
Golgi apparatus protein 1-like, transcript variant X2
Golgi apparatus protein 1-like, transcript variant X1
Golgi apparatus protein 1-like isoform X2
Golgi apparatus protein 1-like isoform X1
mixed lineage kinase domain-like protein, transcript variant X1
mixed lineage kinase domain-like protein, transcript variant X2
mixed lineage kinase domain-like protein
WD repeat domain 59, transcript variant X9
WD repeat domain 59, transcript variant X10
WD repeat domain 59, transcript variant X2
WD repeat domain 59, transcript variant X7
WD repeat domain 59, transcript variant X6
WD repeat domain 59, transcript variant X8
WD repeat domain 59, transcript variant X1
WD repeat domain 59, transcript variant X4
WD repeat domain 59, transcript variant X3
WD repeat domain 59, transcript variant X5
solute carrier family 7 member 6 opposite strand
probable RNA polymerase II nuclear localization protein SLC7A6OS
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
cyclic nucleotide-gated cation channel beta-3-like, transcript variant X1
cyclic nucleotide-gated cation channel beta-3-like, transcript variant X8
cyclic nucleotide-gated cation channel beta-3-like, transcript variant X6
cyclic nucleotide-gated cation channel beta-3-like, transcript variant X4
cyclic nucleotide-gated cation channel beta-3-like, transcript variant X7
cyclic nucleotide-gated cation channel beta-3-like, transcript variant X3
cyclic nucleotide-gated cation channel beta-3-like, transcript variant X5
cyclic nucleotide-gated cation channel beta-3-like, transcript variant X2
cyclic nucleotide-gated cation channel beta-3-like isoform X1
cyclic nucleotide-gated cation channel beta-3-like isoform X7
cyclic nucleotide-gated cation channel beta-3-like isoform X5
cyclic nucleotide-gated cation channel beta-3-like isoform X3
cyclic nucleotide-gated cation channel beta-3-like isoform X6
cyclic nucleotide-gated cation channel beta-3-like isoform X2
cyclic nucleotide-gated cation channel beta-3-like isoform X4
kinesin family member C3, transcript variant X3
kinesin family member C3, transcript variant X2
kinesin family member C3, transcript variant X8
kinesin family member C3, transcript variant X1
kinesin family member C3, transcript variant X6
kinesin family member C3, transcript variant X7
kinesin family member C3, transcript variant X4
kinesin family member C3, transcript variant X5
katanin p80 (WD repeat containing) subunit B 1, transcript variant X1
katanin p80 (WD repeat containing) subunit B 1, transcript variant X2
katanin p80 (WD repeat containing) subunit B 1, transcript variant X3
katanin p80 WD40 repeat-containing subunit B1 isoform X2
katanin p80 WD40 repeat-containing subunit B1 isoform X1
katanin p80 WD40 repeat-containing subunit B1 isoform X3
olfactomedin-4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
olfactomedin-4-like, transcript variant X1
uncharacterized protein LOC122558552 isoform X2
testis, prostate and placenta-expressed protein-like
uncharacterized LOC122558554, transcript variant X2
uncharacterized LOC122558554, transcript variant X1
uncharacterized LOC122558554, transcript variant X3
coiled-coil domain containing 113, transcript variant X2
coiled-coil domain-containing protein 113 isoform X2
coiled-coil domain containing 113, transcript variant X1
coiled-coil domain-containing protein 113 isoform X1
casein kinase 2, alpha prime polypeptide b, transcript variant X1
casein kinase 2, alpha prime polypeptide b, transcript variant X2
casein kinase II subunit alpha' isoform X1
casein kinase II subunit alpha' isoform X2
DNA replication complex GINS protein PSF3
NDRG family member 4, transcript variant X4
NDRG family member 4, transcript variant X3
NDRG family member 4, transcript variant X5
NDRG family member 4, transcript variant X1
NDRG family member 4, transcript variant X2
NDRG family member 4, transcript variant X6
Bardet-Biedl syndrome 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Bardet-Biedl syndrome 2, transcript variant X4
Bardet-Biedl syndrome 2, transcript variant X1
Bardet-Biedl syndrome 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Bardet-Biedl syndrome 2 protein homolog isoform X2
Bardet-Biedl syndrome 2 protein homolog isoform X1
autocrine motility factor receptor a, transcript variant X2
autocrine motility factor receptor a, transcript variant X1
autocrine motility factor receptor a isoform X2
autocrine motility factor receptor a isoform X1
cleavage and polyadenylation specificity factor subunit 5
natural cytotoxicity triggering receptor 3 ligand 1-like
tyrosine-protein phosphatase non-receptor type substrate 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
2-oxoglutarate and iron-dependent oxygenase domain containing 1
immunoglobulin lambda-1 light chain-like, transcript variant X4
immunoglobulin lambda-1 light chain-like, transcript variant X1
immunoglobulin lambda-1 light chain-like, transcript variant X2
immunoglobulin lambda-1 light chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
immunoglobulin lambda-1 light chain-like isoform X1
immunoglobulin lambda-1 light chain-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tyrosine-protein phosphatase non-receptor type substrate 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
endonuclease/exonuclease/phosphatase family domain-containing protein 1-like, transcript variant X3
endonuclease/exonuclease/phosphatase family domain-containing protein 1-like, transcript variant X1
endonuclease/exonuclease/phosphatase family domain-containing protein 1-like, transcript variant X2
endonuclease/exonuclease/phosphatase family domain-containing protein 1-like
uncharacterized protein KIAA0895-like, transcript variant X3
uncharacterized protein KIAA0895-like, transcript variant X2
uncharacterized protein KIAA0895-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein KIAA0895-like isoform X1
uncharacterized protein KIAA0895-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122558571, transcript variant X2
uncharacterized LOC122558571, transcript variant X3
uncharacterized LOC122558571, transcript variant X1
exocyst complex component 3-like protein
tripartite motif containing 71, E3 ubiquitin protein ligase
leucine rich repeat containing 29, transcript variant X1
leucine rich repeat containing 29, transcript variant X2
leucine rich repeat containing 29, transcript variant X3
engulfment and cell motility protein 3-like, transcript variant X2
engulfment and cell motility protein 3-like, transcript variant X1
engulfment and cell motility protein 3-like isoform X1
engulfment and cell motility protein 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
engulfment and cell motility protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62% coverage of the annotated genomic feature by RNAseq alignments
RNA-binding Raly-like protein, transcript variant X1
RNA-binding Raly-like protein, transcript variant X3
RNA-binding Raly-like protein, transcript variant X2
RNA-binding Raly-like protein isoform X2
RNA-binding Raly-like protein isoform X1
RNA-binding Raly-like protein isoform X3
RNA-binding Raly-like protein, transcript variant X4
RNA-binding Raly-like protein isoform X4
vac14 homolog (S. cerevisiae), transcript variant X4
vac14 homolog (S. cerevisiae), transcript variant X3
vac14 homolog (S. cerevisiae), transcript variant X1
vac14 homolog (S. cerevisiae), transcript variant X2
protein MTSS 2-like, transcript variant X17
protein MTSS 2-like, transcript variant X5
protein MTSS 2-like, transcript variant X6
protein MTSS 2-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein MTSS 2-like, transcript variant X11
protein MTSS 2-like, transcript variant X4
protein MTSS 2-like, transcript variant X12
protein MTSS 2-like, transcript variant X13
protein MTSS 2-like, transcript variant X7
protein MTSS 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein MTSS 2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein MTSS 2-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein MTSS 2-like, transcript variant X2
protein MTSS 2-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein MTSS 2-like, transcript variant X15
protein MTSS 2-like, transcript variant X3
protein MTSS 2-like, transcript variant X16
component of oligomeric golgi complex 4, transcript variant X1
component of oligomeric golgi complex 4, transcript variant X2
component of oligomeric golgi complex 4, transcript variant X3
conserved oligomeric Golgi complex subunit 4 isoform X1
conserved oligomeric Golgi complex subunit 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ST3 beta-galactoside alpha-2,3-sialyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2
uncharacterized LOC122558583, transcript variant X3
uncharacterized LOC122558583, transcript variant X1
uncharacterized LOC122558583, transcript variant X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2-like
alanyl-tRNA synthetase 1, transcript variant X1
alanyl-tRNA synthetase 1, transcript variant X2
alanyl-tRNA synthetase 1, transcript variant X3
SET domain containing 6, protein lysine methyltransferase
CCR4-NOT transcription complex, subunit 1
CCR4-NOT transcription complex subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
putative sodium-coupled neutral amino acid transporter 7
aspartate aminotransferase, mitochondrial
purine nucleoside phosphorylase 6, transcript variant X2
purine nucleoside phosphorylase 6, transcript variant X1
purine nucleoside phosphorylase 6, transcript variant X3
purine nucleoside phosphorylase 6 isoform X2
purine nucleoside phosphorylase 6 isoform X1
purine nucleoside phosphorylase 6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
HYDIN axonemal central pair apparatus protein, transcript variant X1
hydrocephalus-inducing protein homolog isoform X1
HYDIN axonemal central pair apparatus protein, transcript variant X2
hydrocephalus-inducing protein homolog isoform X2
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
mitotic spindle assembly checkpoint protein MAD1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
N-terminal EF-hand calcium binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
N-terminal EF-hand calcium binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
N-terminal EF-hand calcium-binding protein 2 isoform X1
N-terminal EF-hand calcium-binding protein 2 isoform X2
solute carrier family 38 member 8a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
putative sodium-coupled neutral amino acid transporter 8a
solute carrier family 38 member 8a, transcript variant X2
oxidative stress-induced growth inhibitor 1-like, transcript variant X2
oxidative stress-induced growth inhibitor 1-like isoform X2
oxidative stress-induced growth inhibitor 1-like, transcript variant X1
oxidative stress-induced growth inhibitor 1-like isoform X1
oxidative stress-induced growth inhibitor 1-like, transcript variant X3
oxidative stress-induced growth inhibitor 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122558695, transcript variant X3
uncharacterized LOC122558695, transcript variant X4
uncharacterized LOC122558695, transcript variant X1
uncharacterized LOC122558695, transcript variant X2
uncharacterized protein LOC122558695 isoform X1
uncharacterized protein LOC122558695 isoform X2
uncharacterized LOC122558696, transcript variant X2
uncharacterized LOC122558696, transcript variant X1
HLA class II histocompatibility antigen, DR beta 5 chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
tapasin-related protein-like, transcript variant X6
tapasin-related protein-like, transcript variant X2
tapasin-related protein-like, transcript variant X1
tapasin-related protein-like, transcript variant X4
tapasin-related protein-like, transcript variant X3
tapasin-related protein-like, transcript variant X5
Ig kappa-b4 chain C region-like, transcript variant X2
Ig kappa-b4 chain C region-like isoform X2
immunoglobulin lambda-1 light chain-like isoform X3
SLA class II histocompatibility antigen, DQ haplotype D beta chain-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
probable G-protein coupled receptor 139, transcript variant X1
probable G-protein coupled receptor 139, transcript variant X2
probable G-protein coupled receptor 139 isoform X1
probable G-protein coupled receptor 139 isoform X2
dynein axonemal assembly factor 1, transcript variant X3
dynein axonemal assembly factor 1, transcript variant X4
dynein axonemal assembly factor 1 isoform X3
dynein axonemal assembly factor 1, transcript variant X2
dynein axonemal assembly factor 1, transcript variant X9
dynein axonemal assembly factor 1, transcript variant X5
dynein axonemal assembly factor 1 isoform X2
dynein axonemal assembly factor 1 isoform X8
dynein axonemal assembly factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dynein axonemal assembly factor 1, transcript variant X8
dynein axonemal assembly factor 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dynein axonemal assembly factor 1, transcript variant X6
dynein axonemal assembly factor 1 isoform X1
dynein axonemal assembly factor 1 isoform X7
dynein axonemal assembly factor 1 isoform X6
dynein axonemal assembly factor 1 isoform X5
dynein axonemal assembly factor 1 isoform X4
dynein axonemal assembly factor 1, transcript variant X10
dynein axonemal assembly factor 1 isoform X9
coenzyme Q9 homolog (S. cerevisiae), transcript variant X1
coenzyme Q9 homolog (S. cerevisiae), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ubiquinone biosynthesis protein COQ9, mitochondrial isoform X1
ubiquinone biosynthesis protein COQ9, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB3
docking protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
docking protein 4, transcript variant X4
docking protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
docking protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
coiled-coil domain-containing protein 102A
zinc finger protein 239-like, transcript variant X4
zinc finger protein 239-like, transcript variant X6
zinc finger protein 239-like, transcript variant X2
zinc finger protein 239-like, transcript variant X5
zinc finger protein 239-like, transcript variant X3
zinc finger protein 239-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns